[News Space=Reporter seungwon lee] Daewoong Pharmaceutical achieved the 'triple crown' by recording the highest sales, operating profit, and operating profit ratio ever for two consecutive years. Daewoong Pharmaceutical (CEO Lee Chang-jae and Park Sung-soo) announced on the 10th that it has once again renewed its best performance since its establishment in just one year with sales of KRW 1.2654 trillion, operating profit of KRW 163.8 billion, and an operating profit ratio of 13% on an individual basis in 2024. In particular, operating profit grew by 23% year-on-year, and the operating profit r
[News Space=Reporter seungwon lee] CJ CheilJedang announced on the 10th that it recorded sales of KRW 17.871 trillion (-0.1%) and operating profit of KRW 1.0323 trillion (+26%) last year. Sales in the fourth quarter were KRW 4.475 trillion and operating profit was KRW 219.9 billion, up 39.2% year-on-year. (Excluding Korea Express) CJ CheilJedang also disclosed its consolidated performance including Korea Express on the 10th. It recorded sales of KRW 29.3591 trillion (+1.2%) and operating profit of KRW 1.553 trillion (+20.2%). The food business division posted sales of KRW 11.353 trillion (+0.8
[News Space=Reporter seungwon lee] Celltrion announced on the 13th that it had obtained product approval from the Ministry of Food and Drug Safety for the subcutaneous injection (SC) formulation of 'Aptozma (development name: CT-P47),' a biosimilar of the autoimmune disease treatment 'Actemra (active ingredient: tocilizumab)'. Based on the results of the global phase 3 clinical trial, Celltrion applied for domestic product approval for the Aptozma SC formulation and received approval for the indication of rheumatoid arthritis (RA). Last year, Celltrion secured the status of ‘first mover’ in th
[News Space=Reporter seungwon lee] KT has achieved its highest annual sales since going public in 1998 through a strategy of strengthening its core business competitiveness by promoting transformation into an AICT company even in difficult external management environments such as the economic recession. KT (CEO Kim Young-seop) recorded consolidated sales of KRW 26.4312 trillion and separate sales of KRW 18.5797 trillion under Korean International Financial Reporting Standards (K-IFRS), up 0.2% and 1.1% year-on-year, respectively. In particular, separate service sales exceeded KRW 16 trillion f
[News Space=Reporter seungwon lee] Hugel (Chairman Cha Suk-yong) renewed its best performance ever last year thanks to the performance of botulinum toxin. This year, Hugel plans to expand its global influence by targeting emerging markets. Following the addition of Chairman Cha Suk-yong, known as a global business expert, the 'Cha Suk-yong magic' is working at Hugel, following LG Household & Health Care, as significant results are being produced. Based on consolidated financial statements, global total medical aesthetics company Hugel achieved its best performance ever with sales of KRW 37
[News Space=Reporter seungwon lee] LG Household & Health Care's On The Body, a household goods company, is being criticized for advertising to an influencer (online celebrity) suspected of 'misandry'. There are even signs that it will spread into an online boycott. LG Household & Health Care deleted the advertisement and posted an apology. On the 7th, LG Household & Health Care ran an advertisement with Influencer A (account ID Jinsu), who has 270,000 subscribers (followers). This influencer recently caused controversy by posting misandry-like comments such as, "Men over 160cm tall
[News Space=Reporter seungwon lee] Pulmuone (CEO Lee Woo-bong) announced on the 13th that it was selected as a top 5 global food company for the second consecutive year in the 2024 Corporate Sustainability Assessment (CSA, formerly DJSI) announced by S&P Global, one of the world's top three credit rating agencies. In this evaluation, Pulmuone once again proved its excellence in sustainable management by recording the highest ranking among domestic food companies and achieving 4th place among global food companies. According to the S&P Yearbook, approximately 7,690 companies worldwide p
[News Space=Reporter seungwon lee] Ceragem (CEO Lee Kyung-soo) announced on the 10th that its 'Master V7' has received approval from the U.S. Food and Drug Administration (FDA). Ceragem is expected to use this as a stepping stone to further strengthen its position in the global medical device market. Ceragem has obtained approval from the U.S. Food and Drug Administration for a total of four indications for 'Master V7', the representative product of the Master series: △improved blood circulation, △relief of muscle pain, △relief of joint pain, and △muscle relaxation. V7 has an added 'cervical (
[News Space=Reporter seungwon lee] CJ Group Chairman Lee Jae-hyun has embarked on his first on-site management activity of the new year. On the afternoon of the 7th, the chairman visited the headquarters of CJ ENM Commerce Division (hereinafter referred to as CJ OnStyle) in Bangbae-dong, Seocho-gu, Seoul, to inspect the business site of CJ OnStyle, which achieved meaningful growth last year, such as expanding transaction amount centered on MLC, and to encourage its performance. The chairman said, “I highly value the fact that CJ OnStyle took the lead in market change last year by using MLC as
[News Space=Reporter seungwon lee] Lotte is holding a ceremony to complete a new plant in India and is starting to attack the Indian market, which has the world's largest population of 1.4 billion. Since entering the Indian market in 2004 through Lotte Welfood, Lotte is currently operating two subsidiaries: Lotte India, a confectionery company, and Havmore, a ice cream company. Lotte Welfood's sales in India are expected to reach KRW 270 billion as of 2023. Lotte Welfood held a completion ceremony for the new Havmore Pune plant in Pune, western India, on the 6th. The ceremony was attended by L